Emergency Drug Bangladesh

  • Home
  • Emergency Drug Bangladesh

Emergency Drug Bangladesh Emergency Drug Bangladesh | The home of Generic Medicine (通用医学). Easy, Trusted and Reliable

https://www.youtube.com/watch?v=N5nJhjpkAPk
29/11/2022

https://www.youtube.com/watch?v=N5nJhjpkAPk

Cancer Diagnosis Tests: Watch this video to listen to Dr. Sachin Marda talking about different diagnostic tests for cancerHow is cancer diagnosed and its sus...

  and   combination is indicated for the treatment of adult patients with chronic   C virus ( ) genotype 1, 2, 3, 4, 5 o...
08/05/2021

and combination is indicated for the treatment of adult patients with chronic C virus ( ) genotype 1, 2, 3, 4, 5 or 6 infection. Without or with compensated cirrhosis. It is a fixed-dose combination tablet containing sofosbuvir and velpatasvir for oral administration. Sofosbuvir is a nucleotide analog HCV NS5B and velpatasvir is an NS5A inhibitor.

Contact us for order.

 , sold under the brand name   among others, is a drug for the treatment of     in adults whose disease was not well con...
24/03/2021

, sold under the brand name among others, is a drug for the treatment of in adults whose disease was not well controlled using RA medications called factor antagonists. It acts as an of janus , blocking the subtypes and .

Contact us for order. Worldwide delivery available.

  is indicated for the treatment of adult patients with moderately to severely active     who have hadan inadequate resp...
21/03/2021

is indicated for the treatment of adult patients with moderately to severely active who have hadan inadequate response or intolerance to . It may beused as or in combination with methotrexate orother nonbiologic disease-modifying drugs( ).

Contact us for order.

 , sold under the brand name   among others, is a targeted therapy medication used to treat certain cases of   myelogeno...
14/03/2021

, sold under the brand name among others, is a targeted therapy medication used to treat certain cases of myelogenous and acute leukemia. Specifically it is used to treat cases that are -positive.

Contact us for order.

  ( ) is indicated for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-...
11/03/2021

( ) is indicated for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell ( ), as detected by an FDA-approved test, whose disease has progressed on or after EGFR (TKI) .
Contact us for order.

  is a once-weekly dipeptidyl peptidase-IV (DPP-4)   . It controls blood glucose levels by selectively and continually i...
28/02/2021

is a once-weekly dipeptidyl peptidase-IV (DPP-4) . It controls blood glucose levels by selectively and continually inhibiting DPP-4, an enzyme that causes the inactivation of glucagon-like peptide-1 and glucagon-dependent insulinotropic , incretin hormones that play an important role in blood regulation. The of DPP-4 increases insulin secretion depending on concentration, thereby controlling blood glucose levels. Wedica is available in tablet form for oral administration.

Worldwide delivery by DHL express, EMS available. Contacts us for order.

 , sold under the brand   among others, is a medication used to treat    ,   arthritis, and   colitis.Contact us for ord...
25/02/2021

, sold under the brand among others, is a medication used to treat , arthritis, and colitis.

Contact us for order.

  is indicated as   for the treatment of adult patients with progressive, IocaIIy advanced or metastatic, differenliated...
20/02/2021

is indicated as for the treatment of adult patients with progressive, IocaIIy advanced or metastatic, differenliated (papillary/foIIicuIar/Hürthle cell) thyroid carcino- ma (DTC), refractory to radioactiva iodine (RAI). Lenvatinib is indicated as monotherapy for the treatment of adult patients with advanced or unresectable hepatocellular carcinoma ( ) who have received no prior systemic #

  is an oral, small-molecule, multi-targeted receptor tyrosine     that was approved by the   for the treatment of renal...
17/02/2021

is an oral, small-molecule, multi-targeted receptor tyrosine that was approved by the for the treatment of renal and imatinib-resistant gastrointestinal stromal on January 26, 2006.

Contact us for order.

Ibrutix ( ) is a kinase   indicated for the treatment of patients with: Mantle Cell   (MCL) who have received at least o...
15/02/2021

Ibrutix ( ) is a kinase indicated for the treatment of patients with: Mantle Cell (MCL) who have received at least one prior , Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL), Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) with 17p deletion, Waldenström’s Macroglobulinemia (WM), Marginal Zone Lymphoma (MZL) who require systemic therapy and have received at least one prior anti-CD20-based therapy. is available in capsule form for oral administration. Capsules should be taken orally with a glass of water. Do not open, break, or chew the capsules.

  is used to treat non-small cell   (NSCLC) that’s metastatic. Metastatic means the   has spread from your   to other pa...
31/01/2021

is used to treat non-small cell (NSCLC) that’s metastatic. Metastatic means the has spread from your to other parts of your body.

Address


Opening Hours

Monday 09:00 - 18:00
Tuesday 09:00 - 18:00
Wednesday 09:00 - 18:00
Thursday 09:00 - 18:00
Saturday 09:00 - 18:00
Sunday 09:00 - 18:00

Telephone

01922101029

Alerts

Be the first to know and let us send you an email when Emergency Drug Bangladesh posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

  • Want your practice to be the top-listed Clinic?

Share